The clinical trial workforce's incredible response to the COVID-19 pandemic has generated some of the most positive media coverage and public acclaim the drug and device research and development industry has ever seen. "We need to harness that public awareness," says Elisa Hurley, PhD, executive director of PRIM&R. Read more
On June 18, 2020, PRIM&R hosted a webinar, Complexity in Clinical Trial Design: A Primer on Adaptive and Platform Trials. During this webinar, Luke Gelinas and Marianne Kearney Chase defined key terms, explored ethical and regulatory challenges, and provided strategies and examples to bridge the gap between IRBs and researchers in understanding adaptive trial designs. Following the webinar, Luke and Marianne reflected on the session and attendee feedback; we're pleased to share their response with the readers of Ampersand. Read more
